Zentalis Pharmaceuticals, Inc.
$336.07M- Market cap
- $287.40M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.98x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.26x
$4.01Latest market snapshot
Implied fair value · at ALHC's multiple
$0.6783.3% below market
0.94 ZNTL revenue / share×0.71x ALHC P/S=$0.67
Market $4.01Implied $0.67
ALHC · current priceP/S 0.71x
$13.56Latest market snapshot
Implied fair value · at ZNTL's multiple
$81.14498.4% above market
19.04 ALHC revenue / share×4.26x ZNTL P/S=$81.14
Market $13.56Implied $81.14